Ballydine, Republic of Ireland
Merck opened a $135 million pharmaceutical R&D facility in Ballydine, Ireland, in September of 2011. Construction began on the project in 2007. Merck will also invest $200 million to expand production operations at its Grange Castle biotechnology center in Clondalkin.
